Researchers at the Institute of Science Tokyo in Japan have developed an artificial intelligence–driven workflow that converts conventional antibody sequences into functional intracellular antibodies that remain stable and active inside living cells. The platform combines protein structure prediction, sequence redesign, and experimental validation to address longstanding challenges in intrabody development.
Intracellular antibodies, often referred to as intrabodies, have significant potential for studying biological processes directly within cells. However, many antibodies fail to fold properly or lose functionality in the intracellular environment. The AI protein design approach redesigns antibody framework regions while preserving antigen-binding domains, improving folding stability without compromising specificity.
The research was published in Science Advances.
Integrated intrabody development pipeline combines computational and experimental methods
The researchers designed an integrated intrabody development workflow that links computational modeling with laboratory screening to accelerate the identification of viable intracellular antibodies. The AI protein design system uses structure prediction followed by sequence optimization and live-cell testing to identify stable candidates more efficiently than traditional approaches.
The team evaluated 26 antibody sequences and successfully converted 19 into functional intracellular antibodies. Notably, 18 of those sequences had previously failed using conventional intrabody development methods, demonstrating the potential of AI-guided redesign to recover otherwise unusable antibody reagents.
Further experiments confirmed that the redesigned intracellular antibodies remained soluble, stable, and highly specific inside cells across varying conditions.
Applications include live-cell imaging and gene regulation studies
The researchers focused on antibodies targeting histone protein modifications, which serve as markers of gene activity and regulatory processes. These molecular targets can be difficult to monitor using traditional techniques, particularly when dynamic changes occur within living cells.
The redesigned intracellular antibodies enabled real-time detection of histone modification levels via fluorescence signals, providing new opportunities to study gene regulatory mechanisms in live-cell environments.
The approach may also support broader applications, including diagnostics, cellular imaging, and therapeutic development, particularly as antibody sequence databases continue to expand.
What this means for laboratory workflows
For laboratory researchers, advances in intracellular antibodies and intrabody development could reduce time and cost associated with generating intracellular probes while expanding the range of usable antibody reagents. Converting existing antibodies into functional intracellular tools may allow laboratories to leverage existing reagent libraries rather than developing new molecules from scratch.
By integrating AI protein design with experimental validation, the workflow demonstrates how artificial intelligence can accelerate molecular tool development and enable more efficient investigation of complex biological processes in research environments.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
